The Antidepressant-like Activity and Cognitive Enhancing Effects of the Combined Administration of (R)-Ketamine and LY341495 in the CUMS Model of Depression in Mice Are Related to the Modulation of Excitatory Synaptic Transmission and LTP in the PFC

(S)-Ketamine is the first rapid-acting antidepressant drug (RAAD) introduced for the treatment of depression. However, research is still being carried out on the search for further RAADs that will be not only effective but also safe to use. Recent data have indicated that the combined administration...

Descripción completa

Detalles Bibliográficos
Autores principales: Pałucha-Poniewiera, Agnieszka, Bobula, Bartosz, Rafało-Ulińska, Anna
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9960441/
https://www.ncbi.nlm.nih.gov/pubmed/37083635
http://dx.doi.org/10.3390/ph16020288

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9960441/
https://www.ncbi.nlm.nih.gov/pubmed/37083635
http://dx.doi.org/10.3390/ph16020288

Ejemplares similares